ArticleArchives of dermatological research2024

Real-world individual and comparative analysis of adverse event reporting for adalimumab and etanercept using public FDA adverse event reporting system data.

Xiaoke Dou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.